medigraphic.com

2004, Number 4

<< Back Next >>

Arch Cardiol Mex 2004; 74 (4)

Mutual Help Groups. Diabetes and hypertension control strategy

Lara EA, Aroch CA, Aurora JR, Arceo GM, Velázquez MO

Language: Spanish
References: 30
Page: 330-336
PDF size: 71.72 Kb.


ABSTRACT

Objective: To evaluate the accomplishment of the treatment basic goals of every person with diabetes type 2 that attend the Mutual Help Groups (GAM) of the Mexican Ministry of Health (SS). Material and methods: This transversal comparative study was carried out in 15 Mexican states, through the accomplishment reports of the treatment basic goals of the GAM integrants by June of 2001, compared to the reported figures by the Health Information System for Open Population (SISPA), Ministry of Health on the same date. The studied variables are: age, sex, blood glucose, blood pressure, body mass index, physical activity and pharmacological treatment. Results: The treatment basic goals accomplishment for 6, 958 people with diabetes was evaluated, all of them attended the Ministry of Health GAMs, in 15 of the 32 Mexican states including the Federal District. When comparing frequencies of patients with diabetes controlled by the GAM and the SISPA, a differential was appreciated, being observed a tendency that showed that people in the GAM were much more controlled; when analyzing with the test Student “t” the differences were even more significant (p < 0.005). The obese diabetics group had a higher risk of being uncontrolled, in relation to the group of non-obese diabetics (OR 1.8, CI: 1.06,1.32; p < 0.002). When comparing the sedentary to the non-sedentary group it was found that the sedentary diabetics presented 1.56 times higher risk of being uncontrolled, that those in the diabetes group that carried out physical activity (CI: 1.37,1.78; p < 0.001). Conclusions: The Mutual Help Groups are a fundamental strategy in the educational line for improving the disease control, since people with diabetes or hypertension and their relatives play an active role in treatment development accomplishment, as well as in the disease prevention and control. Unlike to that reported in the SISPA, the highest benefits of control, are achieved in people with diabetes or hypertension who attend the GAM.


REFERENCES

  1. SSA, Instituto Nacional de Salud Pública, Centro Nacional de Vigilancia Epidemiológica: Encuesta Nacional de Salud 2000, México.

  2. SSA, Dirección General de Estadística e Informática, Mortalidad 1974, 1980, 1987, 1998, 1990-1997, 1999 México.

  3. INEGI/SSA. Dirección General de Información y Evaluación del Desempeño. 2000, México.

  4. Velázquez MO, Rosas PM, Lara EA, Pastelín HG, Grupo ENSA 200, Attie F, et al: Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Méx 2002; 72(1):71-84.

  5. OPS.OMS: Enfermedades Cardiovasculares en especial la Hipertensión Arterial, Washington, D.C. 26 al 30 de julio de 2000.

  6. Sánchez CCP, Velázquez MO, Berber A, Lara EA, Tapia-Conyer R, James PT: Anthropometric cutoff points for predicting chronic diseases in the mexican national health survey 2000. Obesity Research 2003; 11: 442-451.

  7. SSA: Norma Oficial Mexicana: NOM-030-SSA2-1999, para la prevención, tratamiento y control de la hipertensión arterial. México, 2001.

  8. SSA: Actualización de la Norma Oficial Mexicana. NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes México, Nov. 1999.

  9. Barceló A, Robles S, White F, Jodue L, Vega J: Intervención para mejorar el control de la diabetes en Chile. Rev Panam Salud Pública 2001; 10: 1-10.

  10. OPS.OMS: Atlas de Educación en Diabetes en América Latina y el Caribe: Inventario de programas para personas con diabetes tipo 2, Washington, D.C., 2002.

  11. Clark CM: The National Diabetes Education Program, changing the way diabetes is treated. Diabetes Care 2001; 24: 617-618.

  12. Plan Nacional de Desarrollo: Programa Nacional de Salud 2001-2006. México 2001.

  13. SSA, Programa de Acción: Enfermedades Cardiovasculares e Hipertensión Arterial. México 2001.

  14. SSA, Programa de Acción: Diabetes Mellitus, México 2001.

  15. SSA: Coordinación de Vigilancia Epidemiológica. Programa de Salud del adulto y el Anciano. Guía Técnica para el Funcionamiento de Clubes de Diabéticos. México 1998.

  16. Velázquez-Monroy O, Lara-Esqueda A, Martínez-Marroquín M, Tapia-Olarte F, Jiménez RA, Martínez AF: Evaluación de clubes de ayuda mutua. Rev Endocrinol Nutr 2001; 9(3): 126-132.

  17. Organización Mundial de la Salud OMS: Mensaje del día Mundial de la Salud 2002.

  18. National Institutes of Health . National Heart, Lung, and Blood Institute: Heart Disease and Women: Be Physically Active, 1997.

  19. Tuoomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.

  20. González CA, Becerra PA, Carmona SF, Cerezo GM, Hernández HE, Lara EA: Ejercicio físico para la salud. Rev Mex Cardiol 2001; 12(4): 168-180.

  21. Chávez SJ, Lozano DME, Lara EA, Velázquez MO: La actividad física y el deporte en el adulto mayor. Bases fisiológicas. En Prensa 2002.

  22. Secretaría de Salud, Dirección General de Estadística e Informática DGEI: SISPA marzo 2003. México.

  23. SSA, CGPE, Dirección General de Información y Evaluación del Desempeño: SISPA-Subsistema de Recursos. RENIS. México 2002.

  24. OMS: Obesity and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva, 3-5 June 1998.

  25. Consejo Nacional de Población: Conceptos y significados del envejecimiento en las políticas de población. En: Envejecimiento Demográfico de México: Retos y Perspectivas. Primera edición, México, 1999: pp.43-53.

  26. SSA, Dirección General de Información y Evaluación del Desempeño: SISPA junio 2001, México.

  27. UKPDS Group: UK Prospective Diabetes Study. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-852.

  28. UKPDS Group: UK Prospective Diabetes Study. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 7160: 703-713.

  29. The Diabetes Control and Complications Trial Research Group: Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 1996; 19: 195-203.

  30. American Diabetes Association: Implication of the United Kingdom prospective Diabetes study. Diabetes Care 1998; 21(12): 2180-2184.




2020     |     www.medigraphic.com